US drug approvals
59 approvals with a product on the US market
- Famotidine ANDA217982 · approved 2 Jun 2025
- Lisdexamfetamine Dimesylate ANDA215802 · approved 25 Aug 2023
- Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate ANDA215565 · approved 8 Jul 2022
- Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate And Amp Sulfate ANDA214403 · approved 26 Nov 2021
- Chlorpromazine Hydrochloride ANDA212996 · approved 22 Jan 2021
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
